Phibro Animal Health Corporation (PAHC)

Profitability ratios

Return on sales

Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Gross profit margin 31.50% 31.30% 31.33% 31.10% 31.06% 31.38% 31.06% 30.61% 30.50% 30.51% 31.20% 31.89% 32.56% 32.81% 32.90% 32.68% 32.10% 31.97% 31.59% 31.37%
Operating profit margin 5.36% 6.07% 6.01% 6.01% 7.48% 7.42% 7.51% 8.26% 8.44% 8.29% 8.66% 8.65% 8.98% 9.24% 9.40% 9.27% 8.65% 7.72% 7.92% 8.63%
Pretax margin 1.10% 2.68% 2.95% 3.84% 5.63% 4.71% 5.95% 7.21% 7.73% 8.39% 7.62% 6.98% 7.98% 8.35% 8.47% 8.49% 6.94% 5.91% 6.05% 6.41%
Net profit margin 0.24% 1.36% 1.55% 2.17% 3.40% 2.99% 3.80% 4.92% 5.26% 6.48% 6.06% 5.70% 6.53% 5.37% 5.54% 5.38% 4.19% 4.49% 4.68% 5.00%

Phibro Animal Health Corporation's profitability ratios have shown some fluctuations over the periods analyzed. The gross profit margin has been relatively stable, ranging between 30.50% to 31.89%. This indicates the company's ability to generate profits after accounting for the cost of goods sold.

However, the operating profit margin has varied more significantly, fluctuating between 5.36% to 9.40%. Despite the fluctuations, the company has maintained a healthy operating profit margin, showing its efficiency in managing operating expenses.

The pretax margin has also shown variability, ranging from 1.10% to 8.66%. This ratio reflects the company's ability to control non-operating expenses and generate profit before taxes.

In terms of net profit margin, Phibro Animal Health Corporation has shown a similar level of variability, with margins fluctuating between 0.24% to 6.53%. This ratio represents the company's bottom-line profitability after all expenses have been accounted for.

Overall, the company has demonstrated a solid trend in maintaining profitability, but there have been fluctuations in margins that may warrant further investigation to understand the underlying factors driving these changes.


Return on investment

Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Operating return on assets (Operating ROA) 5.43% 5.99% 5.89% 5.95% 7.40% 7.35% 7.44% 8.23% 8.48% 8.21% 8.98% 8.83% 8.90% 9.17% 9.33% 9.47% 8.82% 8.14% 8.17% 8.87%
Return on assets (ROA) 0.25% 1.34% 1.52% 2.15% 3.36% 2.96% 3.77% 4.90% 5.28% 6.42% 6.28% 5.82% 6.46% 5.33% 5.51% 5.49% 4.28% 4.73% 4.83% 5.14%
Return on total capital 7.41% 8.63% 8.77% 9.92% 12.25% 11.30% 13.13% 14.99% 15.88% 13.39% 12.82% 11.67% 12.91% 13.89% 14.01% 14.43% 12.60% 11.62% 11.12% 11.34%
Return on equity (ROE) 0.94% 4.87% 5.46% 7.59% 11.54% 10.50% 13.50% 17.70% 18.74% 22.03% 22.27% 20.84% 22.80% 19.87% 20.74% 22.52% 17.83% 18.79% 17.51% 19.79%

Phibro Animal Health Corporation's profitability ratios show fluctuations over the period under review. The Operating Return on Assets (Operating ROA) has ranged from 5.43% to 9.47%, indicating the company's ability to generate operating income from its assets, with a slight decline in recent quarters. The Return on Assets (ROA) has varied from 0.25% to 6.42%, exhibiting fluctuations in overall profitability levels, possibly due to changes in operating efficiency and asset utilization.

The Return on Total Capital has ranged from 7.41% to 15.88%, showing the company's ability to generate returns for both equity and debt holders. Phibro Animal Health Corporation's Return on Equity (ROE) fluctuated between 0.94% and 22.80%, reflecting the profitability for its shareholders. The ROE demonstrates a strong performance trend, with peaks observed in some quarters.

Overall, the company has shown varying levels of profitability performance over the analyzed periods, with some fluctuations in key ratios. Monitoring these ratios in conjunction with other financial metrics can provide deeper insights into Phibro Animal Health Corporation's financial health and performance trends.